343 related articles for article (PubMed ID: 28287550)
1. Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients.
Boj SF; Vonk AM; Statia M; Su J; Vries RR; Beekman JM; Clevers H
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287550
[TBL] [Abstract][Full Text] [Related]
2. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.
Dekkers JF; Berkers G; Kruisselbrink E; Vonk A; de Jonge HR; Janssens HM; Bronsveld I; van de Graaf EA; Nieuwenhuis EE; Houwen RH; Vleggaar FP; Escher JC; de Rijke YB; Majoor CJ; Heijerman HG; de Winter-de Groot KM; Clevers H; van der Ent CK; Beekman JM
Sci Transl Med; 2016 Jun; 8(344):344ra84. PubMed ID: 27334259
[TBL] [Abstract][Full Text] [Related]
3. A functional CFTR assay using primary cystic fibrosis intestinal organoids.
Dekkers JF; Wiegerinck CL; de Jonge HR; Bronsveld I; Janssens HM; de Winter-de Groot KM; Brandsma AM; de Jong NW; Bijvelds MJ; Scholte BJ; Nieuwenhuis EE; van den Brink S; Clevers H; van der Ent CK; Middendorp S; Beekman JM
Nat Med; 2013 Jul; 19(7):939-45. PubMed ID: 23727931
[TBL] [Abstract][Full Text] [Related]
4. Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids.
Vonk AM; van Mourik P; Ramalho AS; Silva IAL; Statia M; Kruisselbrink E; Suen SWF; Dekkers JF; Vleggaar FP; Houwen RHJ; Mullenders J; Boj SF; Vries R; Amaral MD; de Boeck K; van der Ent CK; Beekman JM
STAR Protoc; 2020 Jun; 1(1):100019. PubMed ID: 33111074
[TBL] [Abstract][Full Text] [Related]
5. Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis.
Ramalho AS; Fürstová E; Vonk AM; Ferrante M; Verfaillie C; Dupont L; Boon M; Proesmans M; Beekman JM; Sarouk I; Vazquez Cordero C; Vermeulen F; De Boeck K;
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32747394
[TBL] [Abstract][Full Text] [Related]
6. β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.
Vijftigschild LA; Berkers G; Dekkers JF; Zomer-van Ommen DD; Matthes E; Kruisselbrink E; Vonk A; Hensen CE; Heida-Michel S; Geerdink M; Janssens HM; van de Graaf EA; Bronsveld I; de Winter-de Groot KM; Majoor CJ; Heijerman HG; de Jonge HR; Hanrahan JW; van der Ent CK; Beekman JM
Eur Respir J; 2016 Sep; 48(3):768-79. PubMed ID: 27471203
[TBL] [Abstract][Full Text] [Related]
7. Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations.
de Winter-de Groot KM; Berkers G; Marck-van der Wilt REP; van der Meer R; Vonk A; Dekkers JF; Geerdink M; Michel S; Kruisselbrink E; Vries R; Clevers H; Vleggaar FP; Elias SG; Heijerman HGM; van der Ent CK; Beekman JM
J Cyst Fibros; 2020 Jul; 19(4):614-619. PubMed ID: 31735562
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity.
Zomer-van Ommen DD; de Poel E; Kruisselbrink E; Oppelaar H; Vonk AM; Janssens HM; van der Ent CK; Hagemeijer MC; Beekman JM
J Cyst Fibros; 2018 May; 17(3):316-324. PubMed ID: 29544685
[TBL] [Abstract][Full Text] [Related]
9. R560S: A class II CFTR mutation that is not rescued by current modulators.
Awatade NT; Ramalho S; Silva IAL; Felício V; Botelho HM; de Poel E; Vonk A; Beekman JM; Farinha CM; Amaral MD
J Cyst Fibros; 2019 Mar; 18(2):182-189. PubMed ID: 30030066
[TBL] [Abstract][Full Text] [Related]
10. CFTR function and clinical response to modulators parallel nasal epithelial organoid swelling.
Anderson JD; Liu Z; Odom LV; Kersh L; Guimbellot JS
Am J Physiol Lung Cell Mol Physiol; 2021 Jul; 321(1):L119-L129. PubMed ID: 34009038
[TBL] [Abstract][Full Text] [Related]
11. R117H-CFTR function and response to VX-770 correlate with mRNA and protein expression in intestinal organoids.
Van Mourik P; van Haaren P; Kruisselbrink E; Korkmaz C; Janssens HM; de Winter-de Groot KM; van der Ent CK; Hagemeijer MC; Beekman JM
J Cyst Fibros; 2020 Sep; 19(5):728-732. PubMed ID: 32061518
[TBL] [Abstract][Full Text] [Related]
12. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.
Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z
Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335
[TBL] [Abstract][Full Text] [Related]
13. Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast.
Latorre RV; Calicchia M; Bigliardi M; Conti J; Kleinfelder K; Melotti P; Sorio C
Respir Investig; 2024 May; 62(3):455-461. PubMed ID: 38547757
[TBL] [Abstract][Full Text] [Related]
14. Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations.
Dekkers JF; Van Mourik P; Vonk AM; Kruisselbrink E; Berkers G; de Winter-de Groot KM; Janssens HM; Bronsveld I; van der Ent CK; de Jonge HR; Beekman JM
J Cyst Fibros; 2016 Sep; 15(5):568-78. PubMed ID: 27160424
[TBL] [Abstract][Full Text] [Related]
15. Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype.
Aalbers BL; Brunsveld JE; van der Ent CK; van den Eijnden JC; Beekman JM; Heijerman HGM
J Cyst Fibros; 2022 Mar; 21(2):254-257. PubMed ID: 35110005
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids.
Chen KG; Zhong P; Zheng W; Beekman JM
Drug Discov Today; 2019 Nov; 24(11):2126-2138. PubMed ID: 31173911
[TBL] [Abstract][Full Text] [Related]
17. A bioassay using intestinal organoids to measure CFTR modulators in human plasma.
Dekkers R; Vijftigschild LA; Vonk AM; Kruisselbrink E; de Winter-de Groot KM; Janssens HM; van der Ent CK; Beekman JM
J Cyst Fibros; 2015 Mar; 14(2):178-81. PubMed ID: 25467948
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing for Cystic Fibrosis: Identification of Drugs That Induce CFTR-Independent Fluid Secretion in Nasal Organoids.
Rodenburg LW; Delpiano L; Railean V; Centeio R; Pinto MC; Smits SMA; van der Windt IS; van Hugten CFJ; van Beuningen SFB; Rodenburg RNP; van der Ent CK; Amaral MD; Kunzelmann K; Gray MA; Beekman JM; Amatngalim GD
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293514
[TBL] [Abstract][Full Text] [Related]
19. FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes.
de Poel E; Spelier S; Hagemeijer MC; van Mourik P; Suen SWF; Vonk AM; Brunsveld JE; Ithakisiou GN; Kruisselbrink E; Oppelaar H; Berkers G; de Winter de Groot KM; Heida-Michel S; Jans SR; van Panhuis H; Bakker M; van der Meer R; Roukema J; Dompeling E; Weersink EJM; Koppelman GH; Blaazer AR; Muijlwijk-Koezen JE; van der Ent CK; Beekman JM
J Cyst Fibros; 2023 May; 22(3):548-559. PubMed ID: 37147251
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic duct organoid swelling is chloride-dependent.
O'Malley Y; Zarei K; Vanegas OGC; Singh P; Apak TI; Coleman M; Thornell IM; Uc A
J Cyst Fibros; 2024 Jan; 23(1):169-171. PubMed ID: 37633792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
